Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 807 results for "daiichi sankyo company"

Innovative Medical Interactive Simulation Session to be presen...

PRWeb Continuing Education Company (CEC) and Daiichi Sankyo Inc have awarded independent educational grants in support of an interaction simulation session entitled "NOACS: What the Evidence Shows in Managing AFib, Stroke Prevention and DVT/PE." ... Industrial Info Financials, 4 hours ago

Daiichi Sankyo Q1 Profit, Revenue Up - Quick Facts

Pharmaceutical company Daiichi Sankyo Company Limited (DSKYF.PK) Friday said first-quarter profit attributable to owners of the company climbed to 34.9 billion yen from 21.6 billion yen in the comparable quarter last year. Operating profit was 49.1 ...
 RTTNews.com4 days ago
Business Standard

Daiichi Sankyo : Revision to 'Results Briefing (Results for Q1 FY2015)'

Release date- 31072015 - Tokyo, Japan - Daiichi Sankyo Company, Limited today announced a revision as follows to the 'Results Briefing (Results for Q1 FY2015)' materials originally disclosed at 1:00pm on Thursday , July 31, 2015 . Revised item ...
 4 Traders1 day ago Daiichi Sankyo acquires Ranbaxy in $4.6B deal  FierceBiotech1 week ago Daiichi Sankyo Announces Details of Executive Share Options  PharmiWeb3 weeks ago DAIICHI SANKYO : Announces Details of Executive Share Options  4 Traders3 weeks ago

Federal Circuit approves PTO's interim procedure on patent term adjustments

Digest of Daiichi Sankyo Company, LTD. v. Michelle K. Lee, Director, United States Patent and Trademark Office, No. 2014-1280 (Fed. Cir. July 2, 2015) (precedential). On appeal from D.D.C. Before Moore, Reyna , and Taranto. Procedural Posture : ...
 Lexology2 weeks ago

Pieris to Get 7th Milestone Payment from Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics [Professional Services Close - Up]

Pieris Pharmaceuticals recently reported it will receive its third milestone payment for the second program in its discovery and development collaboration with Daiichi Sankyo Company, Limited, and seventh milestone payment overall under the multi ...
 Pharmacy Choice2 weeks ago Pieris Pharmaceuticals to Host Second Quarter 2015 Investor Call on August 13th  Sys-Con Canada4 days ago Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock  Sys-Con Italia6 days ago PIERIS PHARMACEUTICALS : to Get 7th Milestone Payment from Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics  4 Traders2 weeks ago

DAIICHI SANKYO : 13th Takamine Memorial Daiichi Sankyo Prize Winner Announced

Release date- 01072015 - Tokyo, Japan - Daiichi Sankyo Company, Limited today announced that its affiliated foundation, the Daiichi Sankyo Foundation of Life Science* (headquarters, Tokyo ; Chairman, Joji Nakayama ) has awarded its 13th Takamine ...
 4 Traders1 month ago 13th Takamine Memorial Daiichi Sankyo Prize Winner Announced  Pharmacy Times1 month ago

Daiichi Sankyo, Plexxikon Inc.'s Rare Disease Drug Shows Promise in Phase I Study

- Fifty-two percent of patients achieved a partial response and 30 percent of patients had stable disease following treatment with PLX3397, an investigational CSF-1R inhibitor - A rare tumor of the joint or tendon sheath, TGCT can lead to ...
 BioSpace4 days ago Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients  Vision Monday5 days ago

Compliance - Hear from CCO from Lundbeck, Daiichi Sankyo and Novartis

With tightening transparency requirements the pharmaceutical industry is under increasing pressure to ensure fully compliant communication and interactions through all areas of their business functions. How can you evolve current business practices ...
 News-Medical.Net1 week ago

Daiichi Sankyo Release: Recommends Once-daily LIXIANA (edoxaban) For The Treatment And Prevention Of Recurrent Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) In Adults

/PRNewswire/ -- NICE Final Appraisal Determination recommends that edoxaban is a cost effective use of NHS resources The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients ...
 BioSpace2 weeks ago NICE recommends new treatment for blood clots  GM Journal3 weeks ago Lixiana (edoxaban) recommended for treating, preventing recurrent DVT and PE in adults  News-Medical.Net3 weeks ago NICE recommends once-daily LIXIANA┬« ? (edoxaban) for the treatment and prevention of recurrent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in adults  Financial Content3 weeks ago

Daiichi Sankyo Release: New Therapy To Help Heart Rhythm Patients Means Doctors Are "Spoilt For Choice"

/PRNewswire/ -- Launch comes as new patients' survey reveals a significant proportion still not receiving adequate treatment for atrial fibrillation, the commonest heart rhythm disorder A new blood-thinning drug therapy to help ...
 BioSpace3 weeks ago New Therapy To Help Heart Rhythm Patients Means Doctors Are "Spoilt For Choice"  TheStreet.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
Get updated on latest news & your favorite topics right in your inbox!
More     Less